171 related articles for article (PubMed ID: 10723589)
1. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation.
Akiyama M; Asai O; Kuraishi Y; Urashima M; Hoshi Y; Sakamaki H; Yabe H; Furukawa T; Yamada O; Mizoguchi H; Yamada H
Bone Marrow Transplant; 2000 Feb; 25(4):441-7. PubMed ID: 10723589
[TBL] [Abstract][Full Text] [Related]
2. Changes of telomere length in children after hematopoietic stem cell transplantation.
Akiyama M; Hoshi Y; Sakurai S; Yamada H; Yamada O; Mizoguchi H
Bone Marrow Transplant; 1998 Jan; 21(2):167-71. PubMed ID: 9489634
[TBL] [Abstract][Full Text] [Related]
3. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
[TBL] [Abstract][Full Text] [Related]
4. Telomere length changes after umbilical cord blood transplant.
Pipes BL; Tsang T; Peng SX; Fiederlein R; Graham M; Harris DT
Transfusion; 2006 Jun; 46(6):1038-43. PubMed ID: 16734822
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.
Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C
Bone Marrow Transplant; 2010 Mar; 45(3):505-12. PubMed ID: 19838219
[TBL] [Abstract][Full Text] [Related]
6. Influence of telomere length on short-term recovery after allogeneic stem cell transplantation.
Widmann TA; Willmann B; Pfreundschuh M; Beelen DW
Exp Hematol; 2005 Oct; 33(10):1257-61. PubMed ID: 16219549
[TBL] [Abstract][Full Text] [Related]
7. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
8. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant.
Robertson JD; Testa NG; Russell NH; Jackson G; Parker AN; Milligan DW; Stainer C; Chakrabarti S; Dougal M; Chopra R
Bone Marrow Transplant; 2001 Jun; 27(12):1283-6. PubMed ID: 11548846
[TBL] [Abstract][Full Text] [Related]
9. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
10. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
11. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
[TBL] [Abstract][Full Text] [Related]
14. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
[TBL] [Abstract][Full Text] [Related]
15. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation.
Lee JJ; Nam CE; Kook H; Maciejewski JP; Kim YK; Chung IJ; Park KS; Lee IK; Hwang TJ; Kim HJ
Bone Marrow Transplant; 2003 Nov; 32(9):947-52. PubMed ID: 14561997
[TBL] [Abstract][Full Text] [Related]
16. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
[TBL] [Abstract][Full Text] [Related]
17. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
[TBL] [Abstract][Full Text] [Related]
18. The potential of patients' peripheral blood mononuclear cells to differentiate into dendritic cells after hematopoietic stem cell transplantation.
Yoshino H; Watanabe N; Takahashi K; Ogura K; Akagi T; Kubo K; Kashiwakura I
Life Sci; 2011 Dec; 89(25-26):946-55. PubMed ID: 22036621
[TBL] [Abstract][Full Text] [Related]
19. Telomeres, X-inactivation ratios, and hematopoietic stem cell transplantation in humans: a review.
Thornley I; Freedman MH
Stem Cells; 2002; 20(3):198-204. PubMed ID: 12004078
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
